|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Additional conditions recognized in this trial | ||||
| Calculi | |||||
| Ureteral Calculi | |||||
| Ureterolithiasis | |||||
| 2 | More general conditions related to this trial | ||||
| Pathological Conditions, Anatomical | |||||
| Ureteral Diseases | |||||
| Urinary Calculi | |||||
| Urolithiasis | |||||
| Urologic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Néfopam | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Nefopam | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Central Nervous System Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| University Hospital, Clermont-Ferrand | |||||